Related Experiment Video

Updated: Feb 22, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

28.5K

Antibiotic Prophylaxis, Immunoglobulin Substitution and Supportive Measures Prevent Infections in MECP2 Duplication

Michael Bauer1, Renate Krüger1, Uwe Kölsch2

  • 1From the Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité University Medicine, Berlin, Germany.

The Pediatric Infectious Disease Journal
|September 23, 2017
PubMed

Insights

MECP2 duplication syndrome patients often die from respiratory infections. This case study shows immunoglobulin substitution and antibiotics significantly reduced pneumonia in a patient with specific antibody deficiencies.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • MECP2 duplication syndrome is a rare genetic disorder associated with significant health complications.
  • Respiratory infections are a primary cause of mortality in individuals with MECP2 duplication syndrome.

Observation:

  • A 20-year-old male patient with MECP2 duplication syndrome presented with recurrent severe pneumonia.
  • The patient exhibited deficiencies in IgG2, IgG4, IgA, and IgM, along with polysaccharide-specific antibody deficiency.

Findings:

  • The patient experienced 46 episodes of pneumonia in his first 13 years and 8 months.
  • Implementing immunoglobulin substitution therapy, dual-agent daily antibiotic prophylaxis, and supportive care reduced pneumonia episodes to four over the subsequent 6 years and 2 months.

Implications:

  • Aggressive management including immunoglobulin replacement and prophylactic antibiotics can mitigate the risk of severe respiratory infections in patients with MECP2 duplication syndrome and combined immunodeficiencies.
  • This highlights the importance of early diagnosis and comprehensive treatment strategies for managing complex pediatric genetic disorders.

More Related Videos

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

6.8K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.4K

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
490
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
246
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
871
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
367